Washington, D.C. (January 12, 2016) – Biotechnology Innovation Organization (BIO) President and CEO Jim Greenwood released the following statement today regarding Vice President Joe Biden’s “moon shot” initiative to find a cure...
BIO announced today that long-time healthcare policy expert Dan Durham will be joining BIO as Executive Vice President and will lead the organization’s Health Policy Section.
Agriculture & Environment, Sustainable Fuels, Renewable Fuel Standard (RFS) • Letters, Testimony & Comments • October 30, 2015
As you finalize the proposed rules under the Renewable Fuel Standard, we respectfully urge you to not reduce the biofuels volume requirements. The RFS program has helped the environment, our economy, and has increased our...
RE: Docket No. FDA–2015–D–2818 Draft Guidance for Industry: Rare Diseases—Common Issues in Drug Development Dear Sir/Madam: The Biotechnology Industry Organization (BIO) appreciates the opportunity to provide feedback in response...
The Biotechnology Industry Organization (BIO) thanks the Food and Drug Administration (FDA) for the opportunity to submit comments to the docket regarding “Complex Issues in Developing Drug and Biologics Products for Rare...
Statement regarding Interactions with Healthcare ProfessionalsBIO and our member companies remain dedicated to the improvement of patient care and the advancement of medical science. In pursuing this mission, we recognize that...
